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Abstract
Chronic acquired neuropathies of unknown origin are classified as chronic inflammatory demyelinating polyneuropathies
(CIDP) and chronic idiopathic axonal polyneuropathies (CIAP). The diagnosis can be very difficult, although it has important
therapeutic implications since CIDP can be improved by immunomodulating treatment. The aim of this study was to
examine the possible abnormalities of nodal and paranodal regions in these two types of neuropathies. Longitudinal
sections of superficial peroneal nerves were obtained from biopsy material from 12 patients with CIDP and 10 patients with
CIAP and studied by immunofluorescence and in some cases electron microscopy. Electron microscopy revealed multiple
alterations in the nodal and paranodal regions which predominated in Schwann cells in CIDP and in axons in CIAP. In CIDP
paranodin/Caspr immunofluorescence was more widespread than in control nerves, extending along the axon in internodes
where it appeared intense. Nodal channels Nav and KCNQ2 were less altered but were also detected in the internodes. In
CIAP paranodes, paranodin labeling was irregular and/or decreased. To test the consequences of acquired primary Schwann
cells alteration on axonal proteins, we used a mouse model based on induced deletion of the transcription factor Krox-20
gene. In the demyelinated sciatic nerves of these mice we observed alterations similar to those found in CIDP by
immunofluorescence, and immunoblotting demonstrated increased levels of paranodin. Finally we examined whether the
alterations in paranodin immunoreactivity could have a diagnosis value. In a sample of 16 biopsies, the study of paranodin
immunofluorescence by blind evaluators led to correct diagnosis in 7064% of the cases. This study characterizes for the first
time the abnormalities of nodes of Ranvier in CIAP and CIDP, and the altered expression and distribution of nodal and
paranodal proteins. Marked differences were observed between CIDP and CIAP and the alterations in paranodin
immunofluorescence may be an interesting tool for their differential diagnosis.
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Introduction
Chronic polyneuropathy is a highly prevalent condition with
various etiologies, including hereditary, metabolic, toxic or
immune-mediated origins. For hereditary polyneuropathies,
termed Charcot-Marie-Tooth (CMT) diseases, recent advances
in the identification of the responsible genes allow a genetic
diagnosis in a growing number of cases [1]. Acquired neuropathies
are more frequent than hereditary neuropathies and their
diagnosis is based on a combination of clinical, electrophysiolog-
ical, biological and, when necessary, histopathological evidence.
Despite thorough investigations, no cause is found in 10–15% of
patients with chronic polyneuropathies [2]. Here, we studied two
types of chronic acquired polyneuropathies whose diagnosis can be
challenging, chronic inflammatory demyelinating polyneuropathy
(CIDP) and chronic idiopathic axonal polyneuropathy (CIAP).
The distinction is important since specific treatment options are
available for CIDP [3], whereas there is none of proven efficacy
for CIAP [4].
CIDP is an immune-mediated disorder of peripheral nerves,
with a progressive or relapsing course [5,6]. Its diagnosis is based
mainly on clinical and electrophysiological features [5,7]. In its
most common clinical presentation, CIDP combines motor deficits
involving proximal and/or distal segments of the limbs, and
superficial and/or deep sensory loss, progressing for at least two
months [5]. Cerebrospinal fluid (CSF) examination often shows
increased protein levels without cells. However, CIDP clinical
presentation may be atypical [8], and electrodiagnostic criteria for
demyelination may be missing because segmental demyelination
affects only a few myelinated fibers or proximal segments not easily
studied by electroneuromyography (ENMG). CIAPs are slowly
progressive distal polyneuropathies, involving sensory or motor
and sensory modalities, for which no cause is found after a
thorough biological investigation [9]. In some cases, CIDP may be
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e14533impossible to differentiate from CIAP on the basis of clinical and
electrophysiological examinations, a situation that requires a nerve
biopsy [10]. This procedure must be performed by trained
physicians and examined in a laboratory with expertise in nerve
pathology, as it requires sophisticated approaches, such as electron
microscopy of transverse sections of peripheral nerve [10,11].
Myelinated fibers are characterized by highly differentiated
domains along the axon, centered by nodes of Ranvier [12,13]. The
voltage-gated Na
+ channels (Nav), essential for the rapid saltatory
conduction of action potentials, are concentrated at nodes of
Ranvier in association with ankyrin G, a cytoplasmic protein
interacting with cortical cytoskeleton and cell adhesion molecules
[14],andKCNQ2potassiumchannels[15].The paranodalseptate-
like junctions separate the nodal and juxtaparanodal regions, attach
the glial loops to the axonal membrane, and restrict the lateral
diffusion of axonal membrane proteins between the node and the
internodal space. Several proteins involved in axoglial contacts have
been identified [12,16], including paranodin [17], also known as
Caspr [18]. Nodal and paranodal proteins are altered in mouse
models of CMT [19,20], and have been investigated in skin biopsies
from CMT patients [21]. However, the possible alterations of nodal
and paranodal regions in CIDP and CIAP are not known. The
purpose of this study was to investigate the nodal and paranodal
regions in these polyneuropathies using both electron microscopy
and immunofluorescence in order to better understand their
pathophysiology and refine their diagnosis.
Results
Nodal and paranodal ultrastructure is differentially
altered in Schwann cells and axons in CIDP and CIAP
Superficial peroneal nerve biopsies were studied in 12 patients
diagnosed with CIDP (Table S1) and 10 with CIAP (Table S2).
We first examined toluidine blue staining of transverse semi-thin
sections (Fig. 1). In contrast with a sample with no sign of
peripheral neuropathy which was considered as a control (Fig. 1A),
hypomyelination (Fig. 1B, arrowheads) and onion bulbs (Fig. 1B,
arrow) were visible in a typical CIDP sample. The CIAP sample
displayed a decreased number of fibers and regeneration clusters
(Fig. 1C, arrowheads).
Since, to our knowledge, the nodal regions have not been
explored in CIDP or CIAP, we used electron microscopy to
determine how these regions were altered in chronic acquired
neuropathies. Ten nodes of Ranvier were examined for either
pathology, in longitudinal sections of nerves from two patients with
CIDPand two with CIAP. In CIDPmyelinated fibers, the abaxonal
cytoplasm and the perinodal extensions of Schwann cells were
abnormal as well as the paranodal glial loops (Fig. 2). The outer
Schwann cell cytoplasm contained multiple large vacuoles some-
times enclosing granular structures (Fig. 2A–D, arrows). The axons
were not entirely normal and the nodal axoplasm included some
vacuolar structures (Fig. 2B). At the level of paranodes, adherens
junctions between adjacent glial loops (Fig. 2C) and axoglial septate
junctions (Fig. 2C, arrowheads) were relatively preserved. However,
some paranodal loops were of irregular size and some contained
lamellar and multivesicular bodies (Fig. 2D, arrowheads).
Figure 1. Transverse semi-thin sections of the musculo-cutane-
ous nerve of a control and patients with chronic acquired
neuropathies. A. Normal density of myelinated fibers in a nerve
without lesion. B. In a CIDP nerve (Patient 12), several hypomyelinated
fibers (arrowheads) and an onion bulb formation (arrow) are visualized.
C. In CIAP nerve (Patient 13), loss in myelinated fibers and numerous
regenerating clusters (arrowheads) are present. Scale bar 30 mm.
doi:10.1371/journal.pone.0014533.g001
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cell microvilli were normal (Figure S1). Some nodes were
heminodes or were flanked by two Schwann cells with different
degrees of myelination, some of which had very thin myelin
(Fig. 3A–C) suggesting that they corresponded to myelination of
regenerating fibers. The axoplasm was rich in organelles (Fig. 3C,
arrows). In other fibers vacuoles of various sizes were frequently
observed in the axoplasm (Fig. 3D–F). In the paranodal region
vacuoles were found in the vicinity of the glial loops, often in
regions with poorly defined axoglial junctions (Fig. 3F, arrow),
whereas other regions displayed normal septate-like junctions
(Fig. 3G arrow, Fig. S1C, arrowhead). The axolemma formed
protrusions which contained cellular organelles, mitochondria,
and vesicles, some of which possibly corresponded to glial
invaginations (Fig. 3G, arrowhead). Thus, electron microscopy
showed the existence of multiple abnormalities of nodal and
paranodal regions in chronic acquired neuropathies.
Alterations in paranodin and Nav immunoreactivities
differ in CIDP and CIAP
Since the nodal and paranodal regions were altered in CIDP
and CIAP we examined the distribution of Nav that are located at
nodes of Ranvier [22], and of paranodin, an axonal membrane
glycoprotein highly enriched at paranodes [17] (Fig. 4). In the
control nerve, Nav immunoreactivity was restricted to nodes of
Ranvier (Fig. 4A, B, red) and flanked by paranodin immunore-
activity, which had a thin extension along the internal mesaxon
(Fig. 4A, B, green), as reported in rodents [17,23]. In CIDP, many
fibers did not display the typical nodal/paranodal immunostaining
described above since paranodin and Nav immunoreactivities had
a punctuate appearance all along the axon (Fig. 4C, D), sometimes
extending between two consecutive nodes (Fig. 4E). This diffuse
distribution was apparent in samples from other patients (Fig. 5).
In contrast, nodal regions appeared usually normal, some with
particularly intense Nav immunofluorescence (Fig. 4C, D asterisk).
In CIAP nerves, paranodin immunoreactivity was distributed
irregularly at paranodes, with areas of weak or absent staining
(Fig. 4F–I). Nav enrichment at nodes appeared normal, although a
diffuse, internodal, punctiform Nav-like immunoreactivity of variable
intensity was also detected in the 10 patients examined (Fig. 4G, H,
arrowhead). Paranodes were sometimes interrupted (Fig. 4G, H, I,
arrow) and heminodes (Fig. 4F, arrow) or asymmetrical nodes were
observed, more frequently in CIAP than in CIDP (1861% of 230
nodes and 7.560.5% of 600 nodes, respectively). Other CIAP
samples displayed a similar pattern of paranodin immunoreactivity,
clearly different from that observed in CIDP (Fig. 5).
KCNQ2 channels are altered in CIDP and CIAP
We then examined the distribution of KCNQ2, a potassium
channel subunit present in nodal regions [15]. As expected,
KCNQ2 and Nav immunofluorescence were colocalized in nodal
regions in control nerves (Fig. 6A). In the six CIDP nerves
examined, the staining intensity of KCNQ2 was diminished or
absent from nodes identified by Nav staining (Fig. 6B). In fibers
displaying a diffuse punctuate distribution of Nav immunoreac-
tivity, KCNQ2 immunoreactivity was also observed along the
fibers (Fig. 6B). In eight CIAP nerves, KCNQ2 immunoreactivity
colocalized with the nodal accumulations of Nav as in controls, but
was also detected in internodal regions in some nerve fibers
(Fig. 6C). Interestingly, wheras Nav and KCNQ2 immunoreac-
tivities colocalized at nodes, it was not the case in the internodes.
A mouse model of induced demyelination leads to
alterations similar to those observed in CIDP
In CIDP patients we observed an altered distribution of
some neuronal proteins. Previous studies have shown that
Figure 2. Ultrastructure of nodes of Ranvier in superficial peroneal nerves from 2 CIDP patients. A. A myelinated fiber (Patient 6) with a
vacuolar inclusion (arrow) in the outer cytoplasm of the Schwann cell. B. A myelinated fiber (Patient 9) displaying numerous vacuoles in the
cytoplasm of the Schwann cell (black arrows). C. Higher magnification showing a vacuole in the Schwann cell (arrow), and intact adherens junctions
(white arrowhead) and septate-like paranodal axoglial junctions (black arrowhead) junctions. Note that paranodal loops are regularly spaced and
tightly linked to the axolemma (black arrowhead). D. Another myelinated fiber from the same patient in which the Schwann cell cytoplasm contains
large vacuoles with granular material (arrow), lamellar and multivesicular bodies (arrowheads). Scale bar: A, 0.6 mm; B, 3 mm; C, 300 nm; D, 1 mm.
doi:10.1371/journal.pone.0014533.g002
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disappearance of paranodal accumulation of proteins [24,25,26].
In these studies no overall increase in paranodin immunoreactivity
was described, in contrast to what was observed in patients with
acquired CIDP. In order to better understand how the
disappearance of differentiated Schwann cells alters axonal
proteins in peripheral nerves, we used a mouse model in which
demyelination is induced in the adult by a mechanism which
targets specifically the Schwann cells [27]. This model is based on
the tamoxifen-induced deletion of the Krox20 gene, which codes
for a transcription factor required for the maintenance of the
expression of Schwann cell-specific genes. Induced demyelination
in adult mice leads to the presence of macrophages degrading
Schwann cells, onion bulbs, and abnormally thin myelin sheaths
[27], which are reminiscent of alterations found in patients with
CIDP. We examined paranodin and ankyrin G expression a
month after tamoxifen treatment (Fig. 7). In vehicle-treated mice,
paranodin and ankyrin G immunostaining were restricted to the
paranodal and nodal regions, respectively (Fig. 7A). Paranodin
immunofluorescence ended rather abruptly at the borders of the
paranodal regions (Fig. 7A, arrow), with the exception of the
labeling along the mesaxon. In tamoxifen-treated mice the limits
of paranodin distribution were less regular and immunostaining
extended into the internodal regions (Fig. 7B). Ankyrin G
immunostaining was present in the nodal region but the density
of these accumulations along the nerve fibers was higher in
tamoxifen-treated (95 10
3610 10
3 nodes per mm
3 mean 6 SEM,
n=3) than in vehicle-treated mice (38 10
3691 0
3 nodes per mm
3,
n=3, t-test p,0.05). To determine whether the increased
immunofluorescence corresponded to increased levels of proteins,
we used immunoblotting (Fig. 7C). The levels of paranodin were
increased in sciatic nerve extracts from tamoxifen-injected mice, as
compared to mice only injected with vehicle (Fig. 7C, D), showing
that the induced demyelination increased the expression of
paranodin.
ThedistributionofNavsodiumchannelswasexaminedindouble
labeling experiments using a polyclonal anti-pan Nav antibody and
the mouse monoclonal antibody SMI 31, which reacts with a
phosphorylated epitope in neurofilaments H and, to a lesser extent,
M. In vehicle-injected mice Nav immunoreactivity was concentrat-
ed in nodal regions identified as the narrowed region of the nerve
fiber stained with SMI31 (Fig. 8A). In tamoxifen-treated mice Nav
diffuse punctuate immunostaining extended all along some axons in
which phosphoneurofilament labeling was very faint (Fig. 8B,
arrow). We also compared the distribution of KCNQ2 and Nav in
this mouse model. As expected, in vehicle-injected mouse KCNQ2
and Nav immunofluorescence were colocalized at nodes (Fig. 8C).
In the tamoxifen-treated mice the staining intensity of KCNQ2 was
diminished or absent in some nodes ¸ while others were normal
(Fig. 8D, arrowhead). A faint punctuate background immunoreac-
tivity was also observed along fibers, which may indicate a diffuse
distribution of KCNQ2.
Paranodin immunofluorescence is a good marker for
diagnosis of CIDP and CIAP
Since paranodin immunostaining appeared to be consistently
different between the two types of chronic neuropathies (see Figs. 4
and 5), we tested whether it could be used as a tool for their
differential diagnosis. For this purpose we used the 17 samples in
which the sections had not been already used for the above studies.
Randomly mixed images from 9 CIDP and 8 CIAP nerve sections
stained with paranodin antibodies were submitted to four observers
unaware of the diagnosis, used to examine immunofluorescence
images but untrained for this specific task. They were requested to
utilize the following criteria: 1/ For CIDP: high global intensity of
paranodinimmunostaining,anditsextension beyond the paranodes
(mesaxon excluded); 2/ For CIAP: low global intensity and/or
interruption and/or presence of hemi-nodes. Only longitudinally
well-oriented fibers were analyzed leading to the exclusion of one
case which was considered to be non-interpretable. The percentage
of correct diagnosis using these two criteria for the 16 interpretable
samples ranged from 63% to 82% (mean 6 SEM: 7064). The
percent agreement between at least three independent observers
was 70%. These results show that examination of paranodin
immunoreactivity on a single section provides a good indication for
the diagnosis of CIAP vs CIDP.
Discussion
The diagnosis of CIDP can be difficult and requires a
combination of criteria, which includes in atypical cases histopath-
ological features [5,8,10], in order to differentiate it from CIAP. In
CIDP, demyelinating features include macrophage-mediated
Figure 3. Ultrastructure of nodes of Ranvier in superficial
peroneal nerves from 2 CIAP patients. A. Low magnification of a
fiber (Patient 14) with a short internodal (IN) distance between two
consecutive heminodal regions (arrowheads), possibly corresponding
to a regenerating fiber. B. Higher magnification of the left heminode in
A showing the thinly myelinated segment (arrowhead). C. Higher
magnification of B. Note the presence of numerous organelles in the
axoplasm (arrows). D. Low magnification of a longitudinal ultrathin
section of a node of Ranvier (NR) region (Patient 20). E. Higher
magnification of D showing axoplasmic vacuoles (arrows). F. Higher
magnification of E showing paranodal junctions (arrowhead) and a
vacuolar space close to the axolemma (arrow). G. Another detail of E
(bottom right) showing paranodal loops with axoglial junctions (arrow)
and axoplasmic protrusions with organelles (arrowhead). Scale bar: A
and D: 2.5 mm, B and E: 20 nm, D, E: 10 mm, C, F, and G: 300 nm.
doi:10.1371/journal.pone.0014533.g003
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These lesions are variably observed and depend when the biopsy is
performed in the course of the disease. CIAPs are characterized by
variable axonal loss, features of axonal regeneration (regeneration
clusters) and no or very few demyelinating lesions [30]. However,
the difference between CIDP and CIAP may be difficult to establish
[30,31]. In the present study we investigated the existence of
alterations of nodes of Ranvier in biopsies from patients with
chronic acquired neuropathies since these regions are critical for the
function of myelinated fibers and the site of early myelin changes in
demyelination [32]. We then examined whether some of these
alterations might help for the diagnosis.
Although electron microscopy of transverse sections of periph-
eral nerves is a classical approach that can contribute to the
diagnosis of peripheral neuropathies, longitudinal sections are
rarely, if ever, used. Nodes of Ranvier that are not easily
investigated in transverse sections have not been characterized in
these conditions. Here we specifically investigated the ultrastruc-
Figure 4. Alterations of nodal and paranodal proteins in chronic acquired neuropathies. Immunolocalization of paranodin (Pnd, green),
voltage-gated Na
+ channels (Nav, red) in longitudinal sections of superficial peroneal nerves (A–I). In blue is shown nuclear staining with topro-8 (E, I)
and neurofilaments (Nf, F). B, D, and H are higher magnifications of A, C, and G, respectively. A, B. In a control nerve paranodin and Nav are correctly
localized in the paranodal (arrows) and nodal (asterisks) regions, respectively. C, D. In CIDP (Patient 1), paranodin immunoreactivity extends to the
internodal regions (double arrows). Nav immunoreactivity remains concentrated in some fibers (asterisk), while it has a diffuse, punctuate pattern
along other fibers (arrow). E. Another CIDP case (Patient 6) with paranodin immunostaining (double arrows) extending in the internode. Nodal
regions are indicated (asterisks). F. In CIAP (Patient 14), in some fibers the paranodal staining appears irregular (arrow). Neurofilaments are in blue. G,
H. In CIAP patient 20, paranodin immunoreactivity is irregular in some nerve fibers with an asymmetrical localization (arrow), whereas the nodal
expression of Nav appears normal (asterisk). A diffuse Nav-like immunoreactivity can be detected along some axons (arrowhead). I. In another CIAP
Patient 13, an interrupted paranodal region (arrow) is visible at high magnification, followed by the normal paranodin staining along the mesaxon.
Scale bar: A, C, E, F, G, 40 mm; B, D, H, 20 mm; I, 1.7 mm.
doi:10.1371/journal.pone.0014533.g004
Acquired Neuropathies
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microscopy demonstrated the existence of alterations of nodal
and paranodal regions in both CIDP and CIAP. As expected,
alterations predominated in Schwann cells in CIDP, and in axons
in CIAP. We also observed internodes with thin myelin or
irregular myelination in CIAP, including heminodes, which were
confirmed by counting after immunostaining. This finding is likely
to correspond to regenerating fibers on which remyelination was
taking place.
Immunofluorescence studies of nodal and paranodal proteins
showed important alterations that were even more pronounced that
what would have been expected from the electron microscopy study.
These results suggest that organization of axonal domains is very
sensitive to pathological alterations of both axons and Schwann cells.
In CIAP, paranodin labeling of paranodes was irregular and
interrupted, in relation to the ultrastructural findings showing axonal
alterations. The relative nodal concentration of KCNQ2 and Nav
channels was preserved, although some Nav immunoreactivity was
detected all along the axons. This pattern of Nav channel
immunostaining may correspond to the extensive zones of sodium
channel staining reported along regenerating axons with ongoing
remyelination after crushing the rat peroneal nerve [33]. Similar
Figure 5. Comparison of paranodin immunoreactivity in several patients with CIDP and CIAP. Longitudinal sections from superficial
peroneal nerves were immunostained with antibodies for paranodin in four patients with CIDP (A) and four patients with CIAP (B). The patient
numbers are indicated on the figure. In CIDP samples paranodin immunoreactivity was visible along the internode in most fibers (A, arrows). In
contrast in CIAP paranodin was restricted to the nodes (B, arrows), which appeared often asymmetrical or irregular. Scale bar 20 mm.
doi:10.1371/journal.pone.0014533.g005
Figure 6. KCNQ2 immunoreactivity in a control nerve and in patients with CIDP and CIAP. Immunolocalization of KCQN2 (green) and
voltage-gated Na
+ channels (Nav, red) in longitudinal sections of superficial peroneal nerves. A. KCNQ2 and Nav immunoreactivities colocalize at the
nodal region in the control nerve (arrowheads) and are not detected in the internodes. B. In a CIDP nerve (Patient 5), nodal KCNQ2 immunoreactivity
is low (asterisk) or absent (arrowhead) and only a few nodes are labeled. A weak immunoreactivity is observed for the two ion channels in some
internodes. C. In a CIAP sample (Patient 18), KCNQ2 and Nav colocalization is observed at nodes (arrowheads) but some immunoreactivity is also
detected along the fibers. Scale bar: 20 mm.
doi:10.1371/journal.pone.0014533.g006
Acquired Neuropathies
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inflammatory and partial axotomy lesion of the rat infraorbital nerve
[34]. Internodal staining for Nav and KCNQ2 observed in our
samples could also correspond in part to intra-axonal vesicles or
vacuoles as detected by electron microscopy, although this could not
be resolved by the methods used. Interestingly the two immunor-
activities did not colocalize in the internodes, suggesting a different
trafficking for these two channels. Thus, in CIAP the axonal
pathology appears to combine abnormalities in nodal and paranodal
regions and consequences of regeneration.
Figure 7. Distribution and levels of paranodin are increased in sciatic nerves in a mouse model of demyelination induced by
conditional Krox 20 inactivation. Sciatic nerve sections were prepared 28 d after a 5-day treatment with vehicle (A) or tamoxifen (B) in
Krox20lacZ/flox, R26-CreER
T mice and immunolabeled for paranodin (Pnd, green) and Nav (red). A. In vehicle-injected animals, paranodin
immunoreactivity is concentrated at paranodes (arrow) on both sides of the nodal Nav accumulations (asterisk). B. In tamoxifen-injected animals,
paranodin immunoreactivity extends outside of the paranodal regions. In a fiber in which the position of the node is indicated by an asterisk,
paranodin immunoreactivity is visualized all along the internodal region (arrowheads). In A and B two magnifications are shown. Scale bar: 45 mm for
the upper panels and 20 mm for the lower panels. C. Western blot analysis of sciatic nerves extracts using an anti-paranodin antibody. Adult brain was
analyzed for comparison. Alpha-tubulin was used for normalization of the quantity of protein. D. Quantification of immunoblot data obtained from
sciatic nerves of 3 different mice (1 nerve per mouse) and in which paranodin immunoreactivity is normalized to alpha-tubulin. Statistical analysis
with Student t-test.
doi:10.1371/journal.pone.0014533.g007
Acquired Neuropathies
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increased and much more diffuse than in normal nerves. These
modifications are likely to result directly from the Schwann cells
alterations revealed by electron microscopy, since the correct
localization of paranodin to the paranodal regions depends on
myelinating glial cells [25,26]. In central myelinated axons from
patients with multiple sclerosis, demyelination results in a diffuse
expression of paranodin [35] and its levels appear downregulated
[36]. Delocalization of paranodin was also observed in Charcot-
Marie-Tooth skin biopsies [21] and in dysmyelinating mutant
mice [20,25]. However, in contrast to these various conditions in
which paranodin levels appeared normal or decreased, we found
an increased paranodin immunoreactivity in CIDP, in addition to
its delocalization. Nav expression appeared also increased in CIDP
nerves and diffusely distributed in internodal regions of some
axons. This is likely to result from the loss of axo-glial contact in
demyelinated axons [37].
To further investigate the alterations of nodal and paranodal
proteins induced by acquired demyelination, we studied mice in
which Schwann cells dedifferentiation can be induced in adult
animals [27]. These mice provide a unique model in which the
genetically targeted and pharmacologically induced disappearance
of a single transcription factor results in the disappearance of
compact myelin. In contrast with toxic chemicals used for inducing
demyelination there is neither Schwann cell death nor lesions of
the axons. This model allows a specific investigation of the
consequences of Schwann cells dedifferentiation on axonal
proteins. As in CIDP, we observed an increased and diffuse
paranodin immunolabeling with a diffusion of Nav immunoreac-
tivity in some fibers. Increased levels of paranodin protein were
demonstrated by immunoblotting, in contrast to what has been
observed in dysmyelinating mutants [20,25]. It is not known
whether this corresponds to an increased production and/or a
diminished destruction of the protein. Interestingly, we observed
an increased density of ankyrin G clusters, presumably corre-
sponding to nodes of Ranvier. This observation is likely to be
related to the proliferation of Schwann cells reported in mice with
tamoxifen-induced Krox20 deletion [27]. This would result in
shorter internodes with an increased density of nodes or
protonodes. In fact some nodes of Ranvier visualized by ankyrin
G or Nav immunoreactivity appeared well preserved, in
agreement with their slower alterations as compared to paranodes
following dysmyelination [20,25,26]. In contrast, other nodes
displayed a decreased KCNQ2 and Nav labeling, which may
correspond to newly formed nodes attesting to the ongoing
remyelination.
Since paranodin immunofluorescence is a robust marker of
paranodes, differently altered in CIDP and CIAP, we tested
whether it could be used as a help to the sometimes difficult
diagnosis of these neuropathies. Using very simple criteria based
on the intensity and distribution of paranodin immunoreactivity,
we found that unaware observers were able to classify correctly
Figure 8. Distribution of voltage-gated Na
+ channels (Nav) and KCNQ2 is altered in sciatic nerves of a mouse model of
demyelination induced by conditional Krox 20 inactivation. Sciatic nerve sections were prepared 28 d after vehicle (A, C) or tamoxifen (B, D)
injections in Krox20lacZ/flox, R26-CreERT mice. A. B. Immunolabeled for Nav (green) and phosphoneurofilament (Nf, antibody SMI31, red). In vehicle-
injected animals, Nav expression is restricted to nodes (asterisks) (A). In tamoxifen-injected animals, Nav immunostaining is visible in nodal regions
(asterisk) and, in some fibers, all along the axon (arrow) with a punctiform pattern (B). C, D. Longitudinal sciatic nerve sections were also doubly
stained with antibodies for KCNQ2 (green) and Nav (red). In control vehicle-injected animals (C), KCNQ2 and Nav immunoreactivities colocalized at
nodes of Ranvier (arrowhead). D. In tamoxifen-injected animals, KCNQ2 immunoreactivity is low and only a few nodes are co-stained (arrowhead)
while in others KCNQ2 immunostaining is weak or absent (asterisks). Scale bar: 20 mm.
doi:10.1371/journal.pone.0014533.g008
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important to note that these observers were not trained, and the
inter-observer variability suggests that the training of the observers
may improve the accuracy. Future studies will examine whether
they can be applied to less invasive biopsy procedures such as
muscle or skin biopsies. In summary, our study characterizes for
the first time the profound alterations of nodes of Ranvier in
human chronic acquired neuropathies using both electron
microscopy and immunofluorescence, and shows that alterations
in paranodin immunofluorescence may provide an interesting
contribution to the diagnosis.
Materials and Methods
Patients
The present study was carried out using remaining material of
biopsies previously carried out for diagnostic purposes. Patients
diagnosed with CIDP and CIAP are described in Tables S1 and S2.
Biopsies were carried out solely for diagnosis purposes before the
present study was initiated and thus, did not need the approval from
the ethics committee. Patients gave their written consent at the time
of biopsy, for further use of possible remaining material for research
purposes. Control nerves were a superficial peroneal nerve and
terminal motor branches of intramuscular nerves in muscle biopsies
devoid of lesion. Biological investigation included complete blood
cell count, sedimentation rate, fasting glucose level, creatininemia,
thyroid function, liver function, vitamin B12, folic acid, assay for
anti-nuclear antibodies, complement, serologies for human immu-
nodeficiency virus, B and C hepatitis, Lyme disease, search for
cryoglobulinemia, monoclonal gammapathy, and cancer. Diagnosis
of CIAP was made in patients with: i) Purely distal polyneuropathy,
involving sensory (patients 19 and 21) or motor and sensory
modalities (patients 13–18, 20, 22); ii) Electrophysiological findings
of axonal degeneration; iii) Absence of abnormalities on biological
investigation; iv) Slowly progressive course after a two-year follow
up (patients 15 and 17 had a nerve biopsy less than two years after
thebeginningofthe disease butfurther follow-updidnotchangethe
diagnosis); v) Absence of the Ad Hoc Subcommittee of the
American Academy of Neurology (AAN) criteria for nerve
demyelination and absence of other identifiable cause of polyneu-
ropathy (absence of vasculitis, granuloma or abnormal deposits)
[28]. Diagnosis of CIDP was based on typical clinical and ENMG
findings in patient 1 only, and in the others on: i) Very suggestive
clinicalpresentationwithproximallimbsinvolvement(patients5,6),
pronounced ataxia (patients 3, 4, 5), diffuse areflexia (patients 5, 8,
11), relapsing course (patient 6), involvement of cranial nerves
(patients 7, 8) and ii) presence of some ENMG criteria for
demyelination (patients 2, 7, 9). These suggestive combination of
clinical and electrophysiological criteria led to measure the CSF
protein content, which was abnormally high in patients 2, 4, 6, 7, 9,
and 12, andto perform a nervebiopsy,whichdisclosed the AAN Ad
Hoc Subcommittee histological criteria for demyelination [28] in
patients 2, 4, 6, 8, and 10–12. Fifty eight percent of the patients
(patients 1–3, 5, 7, 8, and 10) responded favorably to immuno-
modulating treatment.
Mice
Mice with conditional Krox20 inactivation were produced as
described [27]. In brief, these mice carried one allele in which
Krox20 coding sequence was replaced by beta-galactosidase
sequence (lacZ) and one allele in which LoxP sequences allowed
the excision of a critical fragment of the Krox20 coding sequence
following the action of Cre (floxed gene). These mice also carried a
transgene, R26-CreER
T, coding for Cre fused to a mutated form of
the estrogen receptor (ER
T) able to bind tamoxifen but not
endogenous estrogens, which prevents the nuclear activity of Cre.
For inducing Krox20 inactivation, Krox20
lacZ/flox, R26-CreER
T mice
were injected with tamoxifen (10 mg/ml, i.p.), in a 10:1 sunflower
oil/ethanol solution, 100 ml twice a day for 5 days. Control mice
received only vehicle. Mice were killed and nerves prepared 28 days
after this treatment. The total number of mice used was six and all
experiments were in accordance with the guidelines of the French
Agriculture and Forestry Ministry for handling animals (decree
87849, license B75-05-22). Our Institute has the authorization for
the use of mice without approval of specific research project.
Biopsy nerve preparation and electron microscopy
Superficial peroneal nerves were obtained from patients for
diagnosis purposes, previously to the present study, under local
anesthesia, at the lower third lateral part of the leg. One
centimeter was fixed in 2.5% (weight/vol) glutaraldehyde in
sodium phosphate buffer (pH 7.4, 150 mM), post-fixed in 2%
(weight/vol) osmium tetroxide in the same buffer and embedded
in Epon. Semi-thin sections (0.5 mm) were stained with toluidine
blue and examined under light microscope. One centimeter was
orientated longitudinally, mounted on a cork disk with tragacanth
gum and frozen in isopentane cooled by liquid nitrogen at
2160uC. Electron microscopy was carried out on 2 samples from
patients with CIAP and 2 with CIDP at the Institut du Fer a ` Moulin
Cell and Tissue Imaging Facility with a Philips CM 100
microscope equipped with a Gatan Orius 832 camera for digitized
acquisition. Nodal regions were located at low magnification and
extensively studied at higher magnification.
Antibodies
Rabbit antibodies against paranodin (L51) have been described
[17]. Voltage-gated Na
+ channel a subunit mouse monoclonal
antibody (PAN Nav, clone K58/35) and rabbit polyclonal anti-
sodium channel (PAN-SP19) were from Sigma-Aldrich (St Louis,
MO). Rabbit antibodies for KCQN2 [15] were a gift of Je ´ro ˆme
Devaux (CNRS, Marseille, France). Rabbit antibodies for ankyrin
G [38] and neuronal class III b-tubulin (TUJ1), and mouse
monoclonal antibody for ankyrin G were from Chemicon Inc.
(Temecula, CA).
Tissues extracts and immunoblotting
Mouse sciatic nerves were dissected out and frozen in isopentane
pre-cooled with liquid nitrogen. Samples were stored at 280uC.
Tissue fragments (,1m m
3) from frozen nerves were homogenized
in a buffer containing 10 mM sodium phosphate, pH 7.8, 60 mM
NaCl, 1% (vol/vol) Triton X-100, 0.5% (weight/vol) deoxycholic
acid, 0.1% (weight/vol) SDS, 10%(vol/vol)glycerol,25 mM alpha-
glycerol-phosphate, 50 mM sodium fluoride, 2 mM sodium
pyrophosphate, 1 mM sodium orthovanadate, and Complete
protease inhibitor (Roche Applied Science). Insoluble material
was removed by centrifugation at 21,0006g for 10 min at 4uC.
Protein concentration was determined using microBCA (Pierce).
Extracts were in NuPAGE LDS were resolved on 4–12% NuPAGE
BisTris gels (Invitrogen), and transferred to nitrocellulose mem-
branes. Membranes were blocked and incubated with antibodies as
described [39]. Primary antibodies were detected using IRDye 700-
or 800-conjugated secondary antibodies (Rockland) and Odyssey
Imaging System (LI-COR biosciences).
Immunofluorescence
Longitudinal sections of frozen human superficial peroneal
nerve biopsies or mouse sciatic nerves were cryostat-sectioned (8–
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buffered saline (PBS), blocked in PBS with 30 g/L bovine serum
albumin), and incubated overnight at 4uC with the primary
antibody in blocking buffer. After washing in PBS with 0.01%
(vol/vol) Tween 20, sections were incubated 1 hour at room
temperature with Alexa fluor 488 donkey anti-rabbit IgG
(Molecular Probes), Cy3 goat anti-mouse IgG (H+L) highly
cross-adsorbed, or Cy5 goat anti-chicken IgG (Jackson Laborato-
ries) diluted 1/500 in blocking solution. Sections were washed in
distilled water and mounted in Vectashield.
Immunofluorescence analysis was carried out at the Institut du
Fer a ` Moulin Cell and Tissue Imaging facility, using a Leica
epifluorescence microscope equipped with a CCD camera
(Micromax Roper Scientific), or a Leica SP2 confocal laser
scanning microscope (Leica, Mannheim, Germany). Acquisition
features were kept constant for all acquisitions with the same
antibodies.
Validation of paranodin immunofluorescence as a
diagnostic marker
Images from biopsies of CIAP (8) or CIDP (9) immunostained
with paranodin antibodies were coded, randomly mixed and
examined by 4 unaware observers who were asked to classify them
into 3 categories (probable CIAP, probable CIDP, unknown)
according to the intensity and extension of paranodin immuno-
staining. The proportion of correct identification was determined
for each disease.
Supporting Information
Figure S1 Ultrastructure of a node of Ranvier in superficial
peroneal nerve from a CIAP patient. A. Low magnification of a
longitudinal ultrathin section showing the nodal and paranodal
regions. B. Higher magnification of A showing normal perinodal
microvilli emanating from the Schwann cells (arrow). C. Higher
magnification of A showing paranodal loops with septate-like
axoglial junctions (arrowhead). Scale bars: A: 1 mm, B: 0.7 mm and
C: 0.5 mm.
Found at: doi:10.1371/journal.pone.0014533.s001 (3.82 MB TIF)
Table S1 Clinical, paraclinical, and histological characteristics
of CIDP patients.
Found at: doi:10.1371/journal.pone.0014533.s002 (0.02 MB
DOCX)
Table S2 Clinical and histological characteristics of patients with
CIAP.
Found at: doi:10.1371/journal.pone.0014533.s003 (0.02 MB
DOCX)
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